Michal Sapir

Aging has a complex effect on a rat model of ischemic stroke

Shlomo Shapira, Michal Sapir, Ada Wengier et al. · Brain Research · 2002 · 106 citations

Complex Effect, Aging, Ischemic Stroke +15

(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.

Abraham Fisher, Rachel Brandeis, Ishai Karton et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 78 citations

Reversal of age-related cognitive impairments by an M1 cholinergic agonist, AF102B

Rachel Brandeis, Shlomit Dachir, Michal Sapir et al. · Pharmacology Biochemistry and Behavior · 1990 · 75 citations

Neuropsychology, Alzheimer's Disease, Age-related Cognitive Impairments +10

(±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats

Abraham Fisher, Rachel Brandeis, Zipora Pittel et al. · Neuroscience Letters · 1989 · 73 citations

Af64a-treated Rats, Molecular Pharmacology, Medicine +9

Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats

Rachel Brandeis, Michal Sapir, Y. Kapon et al. · Pharmacology Biochemistry and Behavior · 1991 · 63 citations

Neuropsychology, Alzheimer's Disease, Aging +13